New opportunities for the combined therapy of allergic rhinitis in real clinical practice
- 作者: Nazarova E1
-
隶属关系:
- NRC Institute of Immunology FMBA ofRussia
- 期: 卷 16, 编号 1 (2019)
- 页面: 85-89
- 栏目: Articles
- URL: https://journals.rcsi.science/raj/article/view/120520
- DOI: https://doi.org/10.36691/RJA34
- ID: 120520
如何引用文章
全文:
详细
This paper assesses the efficacy of the original combined medication Allergoferon® beta (betamethasone + interferon alpha-2b) in real clinical practice among patients with seasonal allergic rhinitis (AR). The research program results demonstrated a good efficacy of the given medication: there were a decrease in nasal congestion as well as restoration of nasal breathing and in patients with concomitant allergic conjunctivitis - a reduction in the severity of eye symptoms. A low incidence of side effects was observed. It was shown that Allergoferon® beta can be recommended as monotherapy for patients with mild and moderate AR and in complex therapy for patients with severe AR.
作者简介
E Nazarova
NRC Institute of Immunology FMBA ofRussia
Email: Ev.nazarova@nrcii.ru
кандидат медицинских наук, зав. отделением госпитализации.
参考
- Гущин ИС, Ильина НИ, Польнер С.А. Аллергический ринит: Пособие для врачей. ГНЦ «Институт иммунологии», РААКИ. М., 2002
- Allergic Rhinitis and its Impact on Asthma (ARIA) guide-lines-2016 revision; https://wwwjacionline.org/article/S0091-6749(17)30919-3/abstract.
- Bousquet J., Khaltaev N., Cruz AA. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA2LEN and AllerGen). Allergy. 2008;(63):8-160.
- Leynaert B., Bousquet J., Neukirch C. Perennial rhinitis: an independent risk factor for asthma in nonatopic subjects: results from the European Community Respiratory Health Survey. J. Allergy Clin Immunol. 1999;(104):301-304.
- Gergen PJ, Turkeltaub PC. The association of individual allergen reactivity with respiratory disease in a national sample: data from the second National Health and Nutrition Examination Survey, 1976-80 (NHANES II). J. Allergy Clin Immunol. 1992;(90):579-588.
- Pedersen PA, Weeke ER. Asthma and allergic rhinitis in the same patients.Allergy. 1983;(38):25-29.
- Greisner WA, Settipane RJ, Settipane GA. Co-existence of asthma and allergic rhinitis: a 23-year follow-up study of college students. Allergy Asthma Proc. 1998;(19):185-188.
- Guerra S., Sherrill DL, Baldacci S. Rhinitis is an independent risk factor for developing cough apart from colds among adults. Allergy. 2005;(60):343-349.
- Sami AM, Ahmed N., Ahmed S. The effect of novel combination therapy with azelastine hydrochloride and fluticasone propionate in allergic rhinitis. Otolaryngol. (Sunnyvale.) 2016;(6):ID261.
- Лопатин АС, Гущин ИС, Емельянов А.В. Клинические рекомендации по диагностике и лечению аллергического ринита. Consilium medicum. 2001;9:33-44
- Международный консенсус в лечении аллергического ринита (Версия Европейской академии аллергологии и клинической иммунологии, 2000). Российская Ринология. 2000;3:5-30
- Хаитов РМ, Ильина НИ, Латышева Т.В. Рациональная фармакотерапия аллергических заболеваний. М., 2007:502
